
Natco Pharma Launches Carboplatin Injection in US Market, Shares Rise 2%
1 days ago
NATCO Pharma shares rose over 2 percent following the launch of Carboplatin Injection in the US market.
C
CNBC TV18

NATCO Pharma shares rose over 2 percent following the launch of Carboplatin Injection in the US market.



The Grey Market Premium for Jio Platforms IPO reached ₹251 per share on October 19.



